Conventional CT and MR imaging of peritoneal carcinomatosis has a satisfactory performance in most ovarian cancer patients throughout the course of their disease. Nevertheless, as more aggressive ...

To our knowledge, there are no published clinical data on DW-MRI assessment of chemotherapy response in ovarian cancer ... and irregularity of peritoneal carcinomatosis complicates the within ...

Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

Oncoinvent has dosed the first subject in the Phase II clinical trial of Radspherin, an alpha-radiation therapy, for the ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

today announced that the first patient has been dosed in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian cancer. Radspherin® is a novel alpha-radiation ...

the Gastrointestinal Cancer Research Fund, and the Peritoneal Metastasis Research Fund. Confocal imaging and histology core studies were performed with support from the UCSD Specialized Cancer Support ...